Antibody-based assays for phenotyping of extracellular vesicles

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Pugholm, Lotte Hatting ^a   Revenfeld, Anne Louise Schacht ^a   Søndergaard, Evo Kristina Lindersson ^a   Jørgensen, Malene Møller ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; RNA; PROTEIN;

ANTIBODY AFFINITY; ANTIBODY BASED ASSAY; ASSAY; CLINICAL FEATURE; EXOSOME; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; MEMBRANE MICROPARTICLE; MICROFLUIDIC ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHENOTYPE; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN MICROARRAY; REVIEW; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE; ULTRACENTRIFUGATION; CELL COMMUNICATION; CLASSIFICATION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANTIBODIES; CELL COMMUNICATION; EXOSOMES; EXTRACELLULAR VESICLES; HUMANS; PHENOTYPE; PROTEINS; RNA;

EID: 84949987054     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/524817     Document Type: Review

References (108)

1. P. Wolf, "The nature and significance of platelet products in human plasma," British Journal of Haematology, vol. 13, no. 3, pp. 269-288, 1967.
2. M. Szajnik,M. Derbis, M. Lach et al., "Exosomes in plasma of patients with ovarian carcinoma: Potential biomarkers of tumor progression and response to therapy," Gynecology & Obstetrics, supplement 4, article 3, 11 pages, 2013.
3. J. Baran, M. Baj-Krzyworzeka, K. Weglarczyk et al., "Circulating tumour-derived microvesicles in plasma of gastric cancer patients," Cancer Immunology, Immunotherapy, vol. 59, no. 6, pp. 841-850, 2010.
4. G. Rabinowits, C. Gerçel-Taylor, J. M. Day, D. D. Taylor, and G. H. Kloecker, "Exosomal microRNA: A diagnostic marker for lung cancer," Clinical Lung Cancer, vol. 10,no. 1, pp.42-46, 2009.
5. M. Yáñez-Mó, P. R.-M. Siljander, Z. Andreu et al., "Biological properties of extracellular vesicles and their physiological functions," Journal of Extracellular Vesicles, vol. 4, Article ID27066, 2015.
6. S. J. GouldandG. Raposo, "Aswewait: Copingwithanimperfect nomenclature for extracellular vesicles," Journal of Extracellular Vesicles, vol. 2, Article ID20389, 2013.
7. M. P. Oksvold, A. Kullmann, L. Forfang et al., "Expression of B-Cell surface antigens in subpopulations of exosomes released from B-cell lymphoma cells," Clinical Therapeutics, vol. 36, no. 6, pp. 847.e1-862.e1, 2014.
8. J. Chen, C. Li, and L. Chen, "The role of microvesicles derived frommesenchymal stem cells in lung diseases," BioMed Research International, vol. 2015, Article ID 985814, 6 pages, 2015.
9. A. L. S. Revenfeld, R. Bæk, M. H. Nielsen, A. Stensballe, K. Varming, andM. Jørgensen, "Diagnostic and prognostic potential of extracellular vesicles in peripheral blood," ClinicalTherapeutics, vol. 36, no. 6, pp. 830-846, 2014.
10. C. Théry, M. Ostrowski, and E. Segura, "Membrane vesicles as conveyors of immune responses," Nature Reviews Immunology, vol. 9, no. 8, pp. 581-593, 2009.
11. A. V. Vlassov, S. Magdaleno, R. Setterquist, and R. Conrad, "Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials," Biochimica et Biophysica Acta-General Subjects, vol. 1820, no. 7, pp. 940-948, 2012.
12. B. S. Batista,W. S. Eng, K. T. Pilobello, K. D. Hendricks-Muñoz, and L. K.Mahal, "Identification of a conserved glycan signature for microvesicles," Journal of Proteome Research, vol. 10, no. 10, pp. 4624-4633, 2011.
13. L. Garzetti, R.Menon, A. Finardi et al., "Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs," Journal of Leukocyte Biology, vol. 95, no. 5, pp. 817-825, 2014.
14. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee, and J. O. Lötvall, "Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells," Nature Cell Biology, vol. 9, no. 6, pp. 654-659, 2007.
15. J. Skog, T. Würdinger, S. van Rijn et al., "Glioblastoma microvesicles transport RNAand proteins that promote tumour growth and provide diagnostic biomarkers," Nature Cell Biology, vol. 10, no. 12, pp. 1470-1476, 2008.
16. D. M. Pegtel, K. Cosmopoulos, D. A. Thorley-Lawson et al., "Functional delivery of viral miRNAs via exosomes," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 14, pp. 6328-6333, 2010.
17. M. Mittelbrunn, C. Gutiérrez-Vázquez, C. Villarroya-Beltri et al., "Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells," Nature Communications, vol. 2, article 282, 2011.
18. E. van der Pol, A. N. Böing, P. Harrison, A. Sturk, and R. Nieuwland, "Classification, functions, and clinical relevance of extracellular vesicles," Pharmacological Reviews, vol. 64, no. 3, pp. 676-705, 2012.
19. S. El Andaloussi, I. Mäger, X. O. Breakefield, and M. J. A. Wood, "Extracellular vesicles: Biology and emerging therapeutic opportunities," Nature Reviews Drug Discovery, vol. 12, no. 5, pp. 347-357, 2013.
20. B. György, T. G. Szabó, M. Pásztói et al., "Membrane vesicles, current state-of-the-art: Emerging role of extracellular vesicles," Cellular and Molecular Life Sciences, vol. 68, no. 16, pp. 2667-2688, 2011.
21. V. Muralidharan-Chari, J. W. Clancy, A. Sedgwick, and C. D'Souza-Schorey, "Microvesicles: Mediators of extracellular communication during cancer progression," Journal of Cell Science, vol. 123, no. 10, pp. 1603-1611, 2010.
22. J. H. W. Distler, L. C. Huber, S. Gay, O. Distler, and D. S. Pisetsky, "Microparticles as mediators of cellular cross-talk in inflammatory disease," Autoimmunity, vol. 39, no. 8, pp. 683-690, 2006.
23. S. F. Lynch and C. A. Ludlam, "Plasma microparticles and vascular disorders," British Journal of Haematology, vol. 137, pp. 36-48, 2007.
24. M. H. Nielsen, H. Beck-Nielsen, M. Nørgaard Andersen, and A. Handberg, "A flow cytometric method for characterization of circulating cell-derived microparticles in plasma," Journal of Extracellular Vesicles, vol. 3, Article ID 20795, 2014.
25. D. E. Connor, T. Exner, D. D. F. Ma, and J. E. Joseph, "The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib," Thrombosis andHaemostasis, vol. 103, no. 5,pp. 1044-1052, 2010.
26. J. J. Jimenez,W. Jy, L. M. Mauro, C. Soderland, L. L. Horstman, and Y. S. Ahn, "Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis," Thrombosis Research, vol. 109, no. 4, pp. 175-180, 2003.
27. S. Perez-Pujol, P. H.Marker, and N. S. Key, "Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: Studies using a new digital flow cytometer," Cytometry A, vol. 71, no. 1, pp. 38-45, 2007.
28. E.Cocucci,G. Racchetti, and J.Meldolesi, "Shedding microvesicles: Artefacts no more," Trends in Cell Biology, vol. 19, no. 2, pp. 43-51, 2009.
29. C. Verderio, L. Muzio, E. Turola et al., "Myeloid microvesicles are a marker and therapeutic target for neuroinflammation," Annals of Neurology, vol. 72, no. 4, pp. 610-624, 2012.
30. C. Ettelaie, M. E. Collier, A. Maraveyas, and R. Ettelaie, "Characterization of physical properties of tissue factor-containing microvesicles and a comparison of ultracentrifuge-based recovery procedures," Journal of Extracellular Vesicles, vol. 3, 2014.
31. J. C. Akers, D. Gonda, R. Kim, B. S. Carter, and C. C. Chen, "Biogenesis of extracellular vesicles (EV): Exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies," Journal of Neuro-Oncology, vol. 113, no. 1, pp. 1-11, 2013.
32. M.Hristov,W. Erl, S. Linder, and P. C.Weber, "Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro," Blood, vol. 104, no. 9, pp. 2761-2766, 2004.
33. A. M. Cline and M. Z. Radic, "Apoptosis, subcellular particles, and autoimmunity," Clinical Immunology, vol. 112, no. 2,pp. 175-182, 2004.
34. Y. Berda-Haddad, S. Robert, P. Salers et al., "Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1," Proceedings of the National Academy of Sciences of theUnited States of America, vol. 108, no. 51, pp. 20684-20689, 2011.
35. J. A. Schifferli, "Microvesicles are messengers," Seminars in Immunopathology, vol. 33, no. 5, pp. 393-394, 2011.
36. S. F. Mause and C. Weber, "Microparticles: Protagonists of a novel communication network for intercellular information exchange," Circulation Research, vol. 107, no. 9, pp. 1047-1057, 2010.
37. D. A. Shifrin Jr., M. D. Beckler, R. J. Coffey, and M. J. Tyska, "Extracellular vesicles: Communication, coercion, and conditioning," Molecular Biology of the Cell, vol. 24, no. 9, pp. 1253-1259, 2013.
38. Y. J. Yoon, O. Y. Kim, and Y. S. Gho, "Extracellular vesicles as emerging intercellular communicasomes,"BMBReports, vol. 47, no. 10, pp. 531-539, 2014.
39. E. Cocucci and J. Meldolesi, "Ectosomes and exosomes: Shedding the confusion between extracellular vesicles," Trends in Cell Biology, vol. 25, no. 6, pp. 364-372, 2015.
40. M.-P. Caby, D. Lankar, C. Vincendeau-Scherrer, G. Raposo, and C. Bonnerot, "Exosomal-like vesicles are present in human blood plasma," International Immunology, vol. 17, no. 7, pp. 879-887, 2005.
41. T. Pisitkun, R.-F. Shen, and M. A. Knepper, "Identification and proteomic profiling of exosomes in human urine," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 36, pp. 13368-13373, 2004.
42. P. A. Gonzales, T. Pisitkun, J. D. Hoffert et al., "Large-scale proteomics and phosphoproteomics of urinary exosomes," Journal of the American Society ofNephrology, vol. 20,no. 2, pp. 363-379, 2009.
43. Y. Ogawa, M. Kanai-Azuma, Y. Akimoto, H. Kawakami, and R. Yanoshita, "Exosome-like vesicles with dipeptidyl peptidase IV in human saliva," Biological and Pharmaceutical Bulletin, vol. 31, no. 6, pp. 1059-1062, 2008.
44. C. Admyre, S. M. Johansson, K. R. Qazi et al., "Exosomes with immunemodulatory features are present in human breast milk," The Journal of Immunology, vol. 179, no. 3, pp. 1969-1978, 2007.
45. C.Théry, L. Zitvogel, and S. Amigorena, "Exosomes: Composition, biogenesis and function,"Nature Reviews Immunology, vol. 2, no. 8, pp. 569-579, 2002.
46. N.Kosaka, H. Iguchi, Y. Yoshioka, F. Takeshita, Y. Matsuki, and T. Ochiya, "Secretory mechanisms and intercellular transfer of microRNAs in living cells," Journal of Biological Chemistry, vol. 285, no. 23, pp. 17442-17452, 2010.
47. P. J.Mitchell, J.Welton, J. Staffurth et al., "Can urinary exosomes act as treatment response markers in prostate cancer?" Journal of Translational Medicine, vol. 7, article 4, 2009.
48. D.-S. Choi, J. O. Park, S. C. Jang et al., "Proteomic analysis of microvesicles derived from human colorectal cancer ascites," Proteomics, vol. 11, no. 13, pp. 2745-2751, 2011.
49. J. Li, C. A. Sherman-Baust, M. Tsai-Turton, R. E. Bristow, R. B. Roden, and P. J. Morin, "Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer," BMC Cancer, vol. 9, article 244, 2009.
50. K. R. Jakobsen, B. S. Paulsen, R. Bæk, K. Varming, B. S. Sorensen, and M. M. Jørgensen, "Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma," Journal of Extracellular Vesicles, vol. 4, Article ID26659, 2015.
51. M.He, J. Crow,M.Roth, Y. Zeng, andA. K. Godwin, "Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology," Lab on a Chip, vol. 14, no. 19, pp. 3773-3780, 2014.
52. S. Saman, W. Kim, M. Raya et al., "Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease," The Journal of Biological Chemistry, vol. 287, no. 6, pp. 3842-3849, 2012.
53. C. T.Nielsen,O.Ostergaard, O. P. Rekvig, G. Sturfelt, S. Jacobsen, and N. H. Heegaard, "Galectin-3 binding protein links circulating microparticleswith electron dense glomerular deposits in lupus nephritis," Lupus, vol. 24, no. 11, pp. 1150-1160, 2015.
54. O. Stergaard, C. T. Nielsen, L. V. Iversen et al., "Unique protein signature of circulating microparticles in systemic lupus erythematosus," Arthritis and Rheumatism, vol. 65, no. 10, pp. 2680-2690, 2013.
55. V. Viñuela-Berni, L. Doń?z-Padilla, N. Figueroa-Vega et al., "Proportions of several types of plasma and urine microparticles are increased in patients with rheumatoid arthritis with active disease," Clinical & Experimental Immunology, vol. 180, no. 3, pp. 442-451, 2015.
56. B. Escudier, T. Dorval, N. Chaput et al., "Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: Results of the first phase 1 clinical trial," Journal of Translational Medicine, vol. 3, article 10, 2005.
57. M. A. Morse, J. Garst, T. Osada et al., "A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer," Journal of Translational Medicine, vol. 3, article 9, 2005.
58. S. Dai, D.Wei, Z.Wu et al., "Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer,"MolecularTherapy, vol. 16, no. 4, pp. 782-790, 2008.
59. R. C. Lai, F. Arslan, M. M. Lee et al., "Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury," Stem Cell Research, vol. 4, no. 3, pp. 214-222, 2010.
60. L.A.Reis, F. T. Borges,M. J. Sim?oes, A. A. Borges, R. Sinigaglia-Coimbra, and N. Schor, "Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats," PLoS ONE, vol. 7, no. 9,Article ID e44092, 2012.
61. H.Xin,Y. Li, Y. Cui, J. J. Yang,Z.G.Zhang, andM. Chopp, "Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats," Journal of Cerebral Blood Flow and Metabolism, vol. 33, no. 11, pp. 1711-1715, 2013.
62. H. Xin, Y. Li, Z. Liu et al., "MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosomeenriched extracellular particles," Stem Cells, vol. 31, no. 12, pp. 2737-2746, 2013.
63. A.D. Pusic, K. M. Pusic, B. L. L. Clayton, and R. P.Kraig, "IFN-stimulated dendritic cell exosomes as a potential therapeutic for remyelination," Journal of Neuroimmunology, vol. 266, no. 1-2, pp. 12-23, 2014.
64. M. A. Lopez-Verrilli, F. Picou, and F. A. Court, "Schwann cell-derived exosomes enhance axonal regeneration in the peripheral nervous system," Glia, vol. 61, no. 11, pp. 1795-1806, 2013.
65. T. N. Lamichhane, S. Sokic, J. S. Schardt, R. S. Raiker, J.W. Lin, and S.M. Jay, "Emerging roles for extracellular vesicles in tissue engineering and regenerativemedicine," Tissue Engineering Part B: Reviews, vol. 21, no. 1, pp. 45-54, 2015.
66. B.Yu, X. Zhang, andX. Li, "Exosomes derived frommesenchymal stem cells," International Journal of Molecular Sciences, vol. 15, no. 3, pp. 4142-4157, 2014.
67. S.-I. Ohno, M. Takanashi, K. Sudo et al., "Systemically injected exosomes targeted to EGFR deliver antitumor microrna to breast cancer cells," Molecular Therapy, vol. 21, no. 1, pp. 185-191, 2013.
68. L. Alvarez-Erviti, Y. Seow, H. Yin, C. Betts, S. Lakhal, and M. J. A. Wood, "Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes," Nature Biotechnology, vol. 29, no. 4, pp. 341-345, 2011.
69. Y. Tian, S. Li, J. Song et al., "A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy," Biomaterials, vol. 35,no. 7, pp. 2383-2390, 2014.
70. S. F. Kingsmore, "Multiplexed protein measurement: Technologies and applications of protein and antibody arrays," Nature Reviews Drug Discovery, vol. 5, no. 4, pp. 310-320, 2006.
71. M. Lundberg, A. Eriksson, B. Tran, E. Assarsson, and S. Fredriksson, "Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of lowabundant proteins in human blood,"Nucleic Acids Research, vol. 39, no. 15, article e102, 2011.
72. E. Assarsson, M. Lundberg, G. Holmquist et al., "Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability," PLoS ONE, vol. 9, no. 4, Article ID e95192, 2014.
73. D. Juncker, S. Bergeron, V. Laforte, andH. Li, "Cross-reactivity in antibody microarrays and multiplexed sandwich assays: Shedding light on the dark side of multiplexing," Current Opinion in Chemical Biology, vol. 18, no. 1, pp. 29-37, 2014.
74. G. MacBeath, "Protein microarrays and proteomics," Nature Genetics, vol. 32, supplement, pp. 526-532, 2002.
75. H. C. Inglis, A. Danesh, A. Shah, J. Lacroix, P. C. Spinella, and P. J. Norris, "Techniques to improve detection and analysis of extracellular vesicles using flow cytometry," Cytometry Part A, vol. 87, no. 11, pp. 1052-1063, 2015.
76. R. A. Dragovic, J. H. Southcombe, D. S. Tannetta, C.W. G. Redman, and I. L. Sargent, "Multicolor flow cytometry and nanoparticle tracking analysis of extracellular vesicles in the plasma of normal pregnant and pre-eclamptic women," Biology of Reproduction, vol. 89, no. 6, article 151, 2013.
77. E. Van Der Pol, M. J. C. Van Gemert, A. Sturk, R. Nieuwland, and T. G. Van Leeuwen, "Single vs. swarm detection of microparticles and exosomes by flow cytometry," Journal ofThrombosis and Haemostasis, vol. 10, no. 5, pp. 919-930, 2012.
78. E. Van Der Pol, A. G. Hoekstra, A. Sturk, C. Otto, T. G. Van Leeuwen, and R. Nieuwland, "Optical and non-optical methods for detection and characterization of microparticles and exosomes," Journal of Thrombosis and Haemostasis, vol. 8, no. 12, pp. 2596-2607, 2010.
79. E. Van der Pol, F. A. W. Coumans, A. E. Grootemaat et al., "Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing," Journal of Thrombosis and Haemostasis, vol. 12, no. 7, pp. 1182-1192, 2014.
80. N. Baumgarth and M. Roederer, "A practical approach to multicolor flow cytometry for immunophenotyping," Journal of Immunological Methods, vol. 243, no. 1-2, pp. 77-97, 2000.
81. F. Mobarrez, J. Antovic, N. Egberg et al., "A multicolor flow cytometric assay for measurement of platelet-derived microparticles," Thrombosis Research, vol. 125, no. 3, pp. e110-e116, 2010.
82. A. F. Orozco and D. E. Lewis, "Flow cytometric analysis of circulating microparticles in plasma," Cytometry A, vol. 77, no. 6, pp. 502-514, 2010.
83. E. J. Van der Vlist, E. N. M. Nolte-'t Hoen, W. Stoorvogel, G. J. A. Arkesteijn, and M. H. M. Wauben, "Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry," Nature Protocols, vol. 7, no. 7, pp. 1311-1326, 2012.
84. E.N.Nolte-T'Hoen, E. J. vanderVlist,M. Aalberts et al., "Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles," Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 8, no. 5, pp. 712-720, 2012.
85. S. M. Johansson, C. Admyre, A. Scheynius, and S. Gabrielsson, "Different types of in vitro generated humanmonocyte-derived dendritic cells release exosomes with distinct phenotypes," Immunology, vol. 123, no. 4, pp. 491-499, 2008.
86. M. Jayachandran, G. Lugo, H. Heiling, V. M.Miller, A. D. Rule, and J. C. Lieske, "Extracellular vesicles in urine of women with but not without kidney stones manifest patterns similar tomen: A case control study," Biology of Sex Differences, vol. 6, article 2, 11 pages, 2015.
87. V. Pospichalova, J. Svoboda, Z. Dave et al., "Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer," Journal of Extracellular Vesicles, vol. 4, Article ID 25530, 2015.
88. D. Mege, L. Panicot-Dubois, M. Ouaissi et al., "The origin and concentration of circulating microparticles differ according to cancer type and evolution: A prospective single-center study," International Journal of Cancer, 2015.
89. M. Jørgensen, R. Bæk, S. Pedersen, E. K. L. Søndergaard, S. R. Kristensen, and K. Varming, "Extracellular Vesicle (EV) Array: Microarray capturing of exosomes and other extracellular vesicles for multiplexed phenotyping," Journal of Extracellular Vesicles, vol. 2, pp. 1-9, 2013.
90. M. M. Jørgensen, R. Bæk, and K. Varming, "Potentials and capabilities of the Extracellular Vesicle (EV) Array," Journal of Extracellular Vesicles, vol. 4, Article ID 26048, 2015.
91. L. Melton, "Protein arrays: Proteomics in multiplex," Nature, vol. 429, no. 6987, pp. 101-107, 2004.
92. D. A. Hall, J. Ptacek, and M. Snyder, "Protein microarray technology," Mechanisms of Ageing and Development, vol. 128, no. 1, pp. 161-167, 2007.
93. P. J. Peters, J. J. Neefjes, V. Oorschot, H. L. Ploegh, and H. J. Geuze, "Segregation ofMHCclass IImolecules fromMHCclass I molecules in the Golgi complex for transport to lysosomal compartments," Nature, vol. 349, no. 6311, pp. 669-676, 1991.
94. J. N. Glickman, P. A. Morton, J.W. Slot, S. Kornfeld, and H. J. Geuze, "The biogenesis of the MHC class II compartment in human I-cell disease B lymphoblasts," The Journal of Cell Biology, vol. 132, no. 5, pp. 769-785, 1996.
95. G. Raposo, H.W. Nijman,W. Stoorvogel et al., "B lymphocytes secrete antigen-presenting vesicles," Journal of Experimental Medicine, vol. 183, no. 3, pp. 1161-1172, 1996.
96. L. Zhu, K.Wang, J. Cui et al., "Label-free quantitative detection of tumor-derived exosomes through surface plasmon resonance imaging," Analytical Chemistry, vol. 86, no. 17, pp. 8857-8864, 2014.
97. C. T. Campbell and G. Kim, "SPR microscopy and its applications to high-throughput analyses of biomolecular binding events and their kinetics," Biomaterials, vol. 28,no. 15, pp. 2380-2392, 2007.
98. H. Im, H. Shao, Y. Park II et al., "Label-free detection and molecular profiling of exosomeswith a nano-plasmonic sensor," Nature Biotechnology, vol. 32, no. 5, pp. 490-495, 2014.
99. H. Shao, J. Chung, L. Balaj et al., "Protein typing of circulating microvesicles allows real-timemonitoring of glioblastoma therapy," Nature Medicine, vol. 18, no. 12, pp. 1835-1840, 2012.
100. H. Im, A. Lesuffleur, N. C. Lindquist, and S.-H. Oh, "Plasmonic nanoholes in a multichannel microarray format for parallel kinetic assays and differential sensing," Analytical Chemistry, vol. 81, no. 8, pp. 2854-2859, 2009.
101. A. A. Yanik, A. E. Cetin,M.Huang et al., "Seeing proteinmonolayers with naked eye through plasmonic Fano resonances," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 29, pp. 11784-11789, 2011.
102. H. Lee, E. Sun, D. Ham, and R. Weissleder, "Chip-NMR biosensor for detection and molecular analysis of cells," Nature Medicine, vol. 14, no. 8, pp. 869-874, 2008.
103. D. Issadore, C. Min, M. Liong, J. Chung, R. Weissleder, and H. Lee, "Miniature magnetic resonance system for point-of-care diagnostics," Lab on a Chip, vol. 11, no. 13, pp. 2282-2287, 2011.
104. J. B. Haun, N. K. Devaraj, S. A. Hilderbrand, H. Lee, and R. Weissleder, "Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection," Nature Nanotechnology, vol. 5, no. 9, pp. 660-665, 2010.
105. A. Bobrie, M. Colombo, S. Krumeich, G. Raposo, and C. Théry, "Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation," Journal of Extracellular Vesicles, vol. 1, Article ID 18397, 2012.
106. B.György, K.Módos, É. Pállinger et al., "Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters," Blood, vol. 117, no. 4, pp. e39-e48, 2011.
107. K. W. Witwer, E. I. Buzás, L. T. Bemis et al., "Standardization of sample collection, isolation and analysis methods in extracellular vesicle research," Journal of Extracellular Vesicles, vol. 2, Article ID 20360, pp. 1-25, 2013.
108. M. Pla-Roca, R. F. Leulmi, S. Tourekhanova et al., "Antibody colocalization microarray: A scalable technology for multiplex protein analysis in complex samples," Molecular & Cellular Proteomics, vol. 11, no. 4, Article ID M111.011460, 2012.